Sfoglia per Autore
The Current State of Molecular Testing in the BRAF-Mutated Melanoma Landscape
2020-01-01 Vanni, I.; Tanda, E. T.; Spagnolo, F.; Andreotti, V.; Bruno, W.; Ghiorzo, P.
Current State of Target Treatment in BRAF Mutated Melanoma
2020-01-01 Tanda, E. T.; Vanni, I.; Boutros, A.; Andreotti, V.; Bruno, W.; Ghiorzo, P.; Spagnolo, F.
Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications
2020-01-01 Vanni, I.; Tanda, E. T.; Dalmasso, B.; Pastorino, L.; Andreotti, V.; Bruno, W.; Boutros, A.; Spagnolo, F.; Ghiorzo, P.
Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer
2020-01-01 Ottonello, S.; Genova, C.; Cossu, I.; Fontana, V.; Rijavec, E.; Rossi, G.; Biello, F.; Dal Bello, M. G.; Tagliamento, M.; Alama, A.; Coco, S.; Boccardo, S.; Vanni, I.; Ferlazzo, G.; Moretta, L.; Grossi, F.; Mingari, M. C.; Carrega, P.; Pietra, G.
Molecular Assessment in Patients with Melanoma: When and Why?
2021-01-01 Dalmasso, Buna; Vanni, Irene; Bruno, William; Andreotti, Virginia; Pastorino, Lorenza; Spagnolo, Francesco; Ghiorzo, Paola
Relationship between the miRNA Profiles and Oncogene Mutations in Non-Smoker Lung Cancer. Relevance for Lung Cancer Personalized Screenings and Treatments
2021-01-01 Izzotti, Alberto; Gabriela Coronel, Vargas.; Pulliero, Alessandra; Coco, Simona; Vanni, Irene; Colarossi, Cristina; Blanco, Giuseppina; Agodi, Antonella; Barchitta, Martina; Maugeri, Andrea; Cancer Registry Workers, CT-ME-EN; Oliveri Conti, Gea; Ferrante, Margherita; Salvatore Sciacca, And
Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia
2021-01-01 Dalmasso, B; Pastorino, L; Nathan, V; Shah, N N; Palmer, J M; Howlie, M; Johansson, P A; Freedman, N D; Carter, B D; Beane-Freeman, L; Hicks, B; Molven, A; Helgadottir, H; Sankar, A; Tsao, H; Stratigos, A J; Helsing, P; Van Doorn, R; Gruis, N A; Visser, M; Wadt, K A W; Mann, G; Holland, E A; Nagore, E; Potrony, M; Puig, S; Menin, C; Peris, K; Fargnoli, M C; Calista, D; Soufir, N; Harland, M; Bishop, T; Kanetsky, P A; Elder, D E; Andreotti, V; Vanni, I; Bruno, W; Höiom, V; Tucker, M A; Yang, X R; Andresen, P A; Adams, D J; Landi, M T; Hayward, N K; Goldstein, A M; Ghiorzo, P
Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients
2022-01-01 Puccini, Alberto; Ponzano, Marta; Dalmasso, Bruna; Vanni, Irene; Gandini, Annalice; Puglisi, Silvia; Borea, Roberto; Cremante, Malvina; Bruno, William; Andreotti, Virginia; Allavena, Eleonora; Martelli, Valentino; Catalano, Fabio; Grassi, Massimiliano; Iaia, Maria Laura; Pirrone, Chiara; Pastorino, Alessandro; Fornarini, Giuseppe; Sciallero, Stefania; Ghiorzo, Paola; Pastorino, Lorenza
Predictors of germline status for hereditary melanoma: 5 years of multi-gene panel testing within the Italian Melanoma Intergroup
2022-01-01 Bruno, W.; Dalmasso, B.; Barile, M.; Andreotti, V.; Elefanti, L.; Colombino, M.; Vanni, I.; Allavena, E.; Barbero, F.; Passoni, E.; Merelli, B.; Pellegrini, S.; Morgese, F.; Danesi, R.; Calò, V.; Bazan, V.; D’Elia, A. V.; Molica, C.; Gensini, F.; Sala, E.; Uliana, V.; Soma, P. F.; Genuardi, M.; Ballestrero, A.; Spagnolo, F.; Tanda, E.; Queirolo, P.; Mandalà, M.; Stanganelli, I.; Palmieri, G.; Menin, C.; Pastorino, L.; Ghiorzo, P.
A NEXT GENERATION SEQUENCING APPROACH TO GENOMIC LANDSCAPE IN MELANOMA PATIENTS: EVOLUTION OF PATIENT-SPECIFIC RESPONSE TO THERAPY
2022-11-28 Vanni, Irene
Germline POT1 Variants: A Critical Perspective on POT1 Tumor Predisposition Syndrome
2024-01-01 Andreotti, Virginia; Vanni, Irene; Pastorino, Lorenza; Ghiorzo, Paola; Bruno, William
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| The Current State of Molecular Testing in the BRAF-Mutated Melanoma Landscape | 1-gen-2020 | Vanni, I.; Tanda, E. T.; Spagnolo, F.; Andreotti, V.; Bruno, W.; Ghiorzo, P. | |
| Current State of Target Treatment in BRAF Mutated Melanoma | 1-gen-2020 | Tanda, E. T.; Vanni, I.; Boutros, A.; Andreotti, V.; Bruno, W.; Ghiorzo, P.; Spagnolo, F. | |
| Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications | 1-gen-2020 | Vanni, I.; Tanda, E. T.; Dalmasso, B.; Pastorino, L.; Andreotti, V.; Bruno, W.; Boutros, A.; Spagnolo, F.; Ghiorzo, P. | |
| Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer | 1-gen-2020 | Ottonello, S.; Genova, C.; Cossu, I.; Fontana, V.; Rijavec, E.; Rossi, G.; Biello, F.; Dal Bello, M. G.; Tagliamento, M.; Alama, A.; Coco, S.; Boccardo, S.; Vanni, I.; Ferlazzo, G.; Moretta, L.; Grossi, F.; Mingari, M. C.; Carrega, P.; Pietra, G. | |
| Molecular Assessment in Patients with Melanoma: When and Why? | 1-gen-2021 | Dalmasso, Buna; Vanni, Irene; Bruno, William; Andreotti, Virginia; Pastorino, Lorenza; Spagnolo, Francesco; Ghiorzo, Paola | |
| Relationship between the miRNA Profiles and Oncogene Mutations in Non-Smoker Lung Cancer. Relevance for Lung Cancer Personalized Screenings and Treatments | 1-gen-2021 | Izzotti, Alberto; Gabriela Coronel, Vargas.; Pulliero, Alessandra; Coco, Simona; Vanni, Irene; Colarossi, Cristina; Blanco, Giuseppina; Agodi, Antonella; Barchitta, Martina; Maugeri, Andrea; Cancer Registry Workers, CT-ME-EN; Oliveri Conti, Gea; Ferrante, Margherita; Salvatore Sciacca, And | |
| Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia | 1-gen-2021 | Dalmasso, B; Pastorino, L; Nathan, V; Shah, N N; Palmer, J M; Howlie, M; Johansson, P A; Freedman, N D; Carter, B D; Beane-Freeman, L; Hicks, B; Molven, A; Helgadottir, H; Sankar, A; Tsao, H; Stratigos, A J; Helsing, P; Van Doorn, R; Gruis, N A; Visser, M; Wadt, K A W; Mann, G; Holland, E A; Nagore, E; Potrony, M; Puig, S; Menin, C; Peris, K; Fargnoli, M C; Calista, D; Soufir, N; Harland, M; Bishop, T; Kanetsky, P A; Elder, D E; Andreotti, V; Vanni, I; Bruno, W; Höiom, V; Tucker, M A; Yang, X R; Andresen, P A; Adams, D J; Landi, M T; Hayward, N K; Goldstein, A M; Ghiorzo, P | |
| Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients | 1-gen-2022 | Puccini, Alberto; Ponzano, Marta; Dalmasso, Bruna; Vanni, Irene; Gandini, Annalice; Puglisi, Silvia; Borea, Roberto; Cremante, Malvina; Bruno, William; Andreotti, Virginia; Allavena, Eleonora; Martelli, Valentino; Catalano, Fabio; Grassi, Massimiliano; Iaia, Maria Laura; Pirrone, Chiara; Pastorino, Alessandro; Fornarini, Giuseppe; Sciallero, Stefania; Ghiorzo, Paola; Pastorino, Lorenza | |
| Predictors of germline status for hereditary melanoma: 5 years of multi-gene panel testing within the Italian Melanoma Intergroup | 1-gen-2022 | Bruno, W.; Dalmasso, B.; Barile, M.; Andreotti, V.; Elefanti, L.; Colombino, M.; Vanni, I.; Allavena, E.; Barbero, F.; Passoni, E.; Merelli, B.; Pellegrini, S.; Morgese, F.; Danesi, R.; Calò, V.; Bazan, V.; D’Elia, A. V.; Molica, C.; Gensini, F.; Sala, E.; Uliana, V.; Soma, P. F.; Genuardi, M.; Ballestrero, A.; Spagnolo, F.; Tanda, E.; Queirolo, P.; Mandalà, M.; Stanganelli, I.; Palmieri, G.; Menin, C.; Pastorino, L.; Ghiorzo, P. | |
| A NEXT GENERATION SEQUENCING APPROACH TO GENOMIC LANDSCAPE IN MELANOMA PATIENTS: EVOLUTION OF PATIENT-SPECIFIC RESPONSE TO THERAPY | 28-nov-2022 | Vanni, Irene | |
| Germline POT1 Variants: A Critical Perspective on POT1 Tumor Predisposition Syndrome | 1-gen-2024 | Andreotti, Virginia; Vanni, Irene; Pastorino, Lorenza; Ghiorzo, Paola; Bruno, William |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile